I can help you decide whether Wegovy Flextouch 0.25 mg might be appropriate given your height, weight and HbA1c.

⚕️ What this likely means

• Your height 5 ft 2 in and weight 87 kg gives a Body Mass Index (BMI) ≈ 35 kg/m², which meets common criteria for prescription weight-loss treatment.
• Your glycated hemoglobin (HbA1c) 6.5% is at the diagnostic threshold for diabetes, so blood‑sugar management is relevant before/while starting therapy.
• Wegovy (semaglutide) is available in India as a prescription injection; 0.25 mg is the usual initial weekly titration dose, not a full therapeutic dose.

💊 Practical next steps

• See an endocrinologist (or obesity specialist) for a clinical assessment and prescription—this drug is prescription-only.
• Ask the doctor for baseline tests: kidney function, liver tests, thyroid evaluation, and confirm recent HbA1c.
• If cleared, expect supervised dose escalation from 0.25 mg weekly per local prescribing plan and monitoring for glucose changes.

⚠️ Warnings / when to stop and seek help

• Severe persistent abdominal pain (possible pancreatitis).
• Pregnancy, planning pregnancy, or breastfeeding.
• Personal/family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2).

🩺 Follow-up

• Are you currently on any diabetes medications or insulin?
• Any history of pancreatitis or thyroid cancer in you or your family?
• Are you pregnant/planning pregnancy or breastfeeding?

If you want, I can explain typical titration schedules, likely side effects, or monitoring plans in more detail.